Trial · NCT01103713
Results by group102
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 102
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With Parasitologic Response (Polymerase Chain Reaction (PCR) Corrected) at Day 28 Post First Dose of Study Medication | Azithromycin (AZ)/Chloroquine (CQ) | 99.35 | 95% Confidence Interval 97.76 to 100.00 | Percentage of participants | |
| Percentage of Participants With Parasitologic Response (PCR Corrected) at Day 28 Post First Dose of Study Medication | Azithromycin (AZ)/Chloroquine (CQ) | 99.35 | 95% Confidence Interval 97.76 to 100.00 | Percentage of participants | |
| Percentage of Participants With Parasitologic Response (PCR Corrected) at Days 7, 14, 21, 35, and 42 Post First Dose of Study Medication | Azithromycin/Chloroquine (AZCQ) | Day 7 (n=156) | 100 | 95% Confidence Interval 97.66 to 100.00 | Percentage of participants |
| Percentage of Participants With Parasitologic Response (PCR Corrected) at Days 7, 14, 21, 35, and 42 Post First Dose of Study Medication | Azithromycin/Chloroquine (AZCQ) | Day 14 (n=154) | 100 | 95% Confidence Interval 97.63 to 100.00 | Percentage of participants |
| Percentage of Participants With Parasitologic Response (PCR Corrected) at Days 7, 14, 21, 35, and 42 Post First Dose of Study Medication | Azithromycin/Chloroquine (AZCQ) | Day 21 (n=154) | 100 | 95% Confidence Interval 97.63 to 100.00 | Percentage of participants |
| Percentage of Participants With Parasitologic Response (PCR Corrected) at Days 7, 14, 21, 35, and 42 Post First Dose of Study Medication | Azithromycin/Chloroquine (AZCQ) | Day 35 (n=148) | 96.65 | 95% Confidence Interval 93.42 to 99.87 | Percentage of participants |
| Percentage of Participants With Parasitologic Response (PCR Corrected) at Days 7, 14, 21, 35, and 42 Post First Dose of Study Medication | Azithromycin/Chloroquine (AZCQ) | Day 42 (n=138) | 95.19 | 95% Confidence Interval 91.35 to 99.03 | Percentage of participants |
| Percentage of Participants With Parasitologic Response (PCR Corrected) at Days 7, 14, 21, 35, and 42 , Post First Dose of Study Medication | Azithromycin (AZ)/Chloroquine (CQ) | Day 7 (n=156) | 100.00 | 95% Confidence Interval 97.66 to 100.00 | Percentage of participants |
| Percentage of Participants With Parasitologic Response (PCR Corrected) at Days 7, 14, 21, 35, and 42 , Post First Dose of Study Medication | Azithromycin (AZ)/Chloroquine (CQ) | Day 14 (n=154) | 100.00 | 95% Confidence Interval 97.63 to 100.00 | Percentage of participants |
| Percentage of Participants With Parasitologic Response (PCR Corrected) at Days 7, 14, 21, 35, and 42 , Post First Dose of Study Medication | Azithromycin (AZ)/Chloroquine (CQ) | Day 21 (n=154) | 100.00 | 95% Confidence Interval 97.63 to 100.00 | Percentage of participants |
| Percentage of Participants With Parasitologic Response (PCR Corrected) at Days 7, 14, 21, 35, and 42 , Post First Dose of Study Medication | Azithromycin (AZ)/Chloroquine (CQ) | Day 35 (n=148) | 96.65 | 95% Confidence Interval 93.42 to 99.87 | Percentage of participants |
| Percentage of Participants With Parasitologic Response (PCR Corrected) at Days 7, 14, 21, 35, and 42 , Post First Dose of Study Medication | Azithromycin (AZ)/Chloroquine (CQ) | Day 42 (n=138) | 95.19 | 95% Confidence Interval 91.35 to 99.03 | Percentage of participants |
| Percentage of Participants With Parasitologic Response (PCR Corrected) at Days 7, 14, 21, 28, 35, and 42 Post First Dose of Study Medication | Azithromycin (AZ)/Chloroquine (CQ) | Day 7 (n=158) | 100.00 | 95% Confidence Interval 97.69 to 100.00 | Percentage of participants |
| Percentage of Participants With Parasitologic Response (PCR Corrected) at Days 7, 14, 21, 28, 35, and 42 Post First Dose of Study Medication | Azithromycin (AZ)/Chloroquine (CQ) | Day 14 (n=156) | 100.00 | 95% Confidence Interval 97.66 to 100.00 | Percentage of participants |
| Percentage of Participants With Parasitologic Response (PCR Corrected) at Days 7, 14, 21, 28, 35, and 42 Post First Dose of Study Medication | Azithromycin (AZ)/Chloroquine (CQ) | Day 21 (n=156) | 100.00 | 95% Confidence Interval 97.66 to 100.00 | Percentage of participants |
| Percentage of Participants With Parasitologic Response (PCR Corrected) at Days 7, 14, 21, 28, 35, and 42 Post First Dose of Study Medication | Azithromycin (AZ)/Chloroquine (CQ) | Day 28 (n=156) | 99.36 | 95% Confidence Interval 97.79 to 100.00 | Percentage of participants |
| Percentage of Participants With Parasitologic Response (PCR Corrected) at Days 7, 14, 21, 28, 35, and 42 Post First Dose of Study Medication | Azithromycin (AZ)/Chloroquine (CQ) | Day 35 (n=150) | 96.69 | 95% Confidence Interval 93.51 to 99.88 | Percentage of participants |
| Percentage of Participants With Parasitologic Response (PCR Corrected) at Days 7, 14, 21, 28, 35, and 42 Post First Dose of Study Medication | Azithromycin (AZ)/Chloroquine (CQ) | Day 42 (n=140) | 95.26 | 95% Confidence Interval 91.47 to 99.05 | Percentage of participants |
| Percentage of Participants With Parasitologic Response (PCR Uncorrected) at Days 7, 14, 21, 28, 35, and 42 Post First Dose of Study Medication | Azithromycin (AZ)/Chloroquine (CQ) | Day 7 (n=156) | 100.00 | 95% Confidence Interval 97.66 to 100.00 | Percentage of participants |
| Percentage of Participants With Parasitologic Response (PCR Uncorrected) at Days 7, 14, 21, 28, 35, and 42 Post First Dose of Study Medication | Azithromycin (AZ)/Chloroquine (CQ) | Day 14 (n=154) | 100.00 | 95% Confidence Interval 97.63 to 100.00 | Percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01103713/results